Bryogen Pharmaceuticals Private Limited

Bryogen Pharmaceuticals Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
CIN U24232HR2010PTC041648 Incorporated 02 December 2010 ROC Haryana HQ Gurgaon, Haryana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹13.32 Cr
▲ 108% YoY
Net profit · FY 2025
₹2.75 Cr
Net margin 20.6%
EBITDA · FY 2025
₹3.94 Cr
EBITDA margin 29.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹1.22 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings

About Bryogen Pharmaceuticals Private Limited

Data last updated:

Bryogen Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 December 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2010PTC041648. Its GSTIN is 07AAECB3968P1Z1 (Delhi). The company holds 5 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Rohit Tripathi and Manish Tripathi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building 10 Tower A Level 1 DLF Cyber City Phase III, Gurgaon, Haryana, India – 122002.

As per the financials filed for FY 2025, the company reported a revenue of ₹13.32 Cr, a growth of 108% compared to the previous year. For the same year it recorded a net profit of ₹2.75 Cr (net margin 20.6%) and EBITDA of ₹3.94 Cr (EBITDA margin 29.6%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 32% over five years.

The company is associated with 1 brand: Bryogen. As per MCA filings, the company has open charges of ₹1.22 Cr on record. Court records list 9 cases involving the company, including 6 filed by the company and 3 filed against it; 3 cases are pending.

Bryogen Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0006396). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bryogen.in.

Company details

CIN U24232HR2010PTC041648
Registration Number 041648
Incorporation Date 02 December 2010
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-05-0006396
Key People
Rohit Tripathi Director Manish Tripathi Director

Recognitions & Rankings of Bryogen Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-05-0006396

Contact details

Bryogen Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its website is bryogen.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    bryogen.in
  • Registered Address
    Building 10 Tower A Level 1 DLF Cyber City Phase III, Gurgaon, Haryana, India – 122002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bryogen Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Bryogen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Bryogen Pharmaceuticals operates one associated brand: Bryogen. Each brand links to its own profile.

BrandDescriptionWebsite
Bryogen
Manufacturer of generic solid and liquid dosage formsbryogen.in

Business activity

The main business activity of Bryogen Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Bryogen Pharmaceuticals Private Limited, buy the company report.

Financials of Bryogen Pharmaceuticals Private Limited

FY 2025 filings available

Bryogen Pharmaceuticals Private Limited reported revenue of ₹13.32 Cr (up 108% YoY) for FY 2025.

Revenue · FY 2025
₹13.32 Cr ▲ 108%
Net profit · FY 2025
₹2.75 Cr margin 20.6%
EBITDA · FY 2025
₹3.94 Cr margin 29.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 30%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 213%
3 years · compounded
▲ 83%
5 years · compounded
▲ 44%

Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 108% growth in the latest year. EBITDA rose 213% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.94 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.75 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin29.6%
Net Profit Margin20.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bryogen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Bryogen Pharmaceuticals Private Limited

Bryogen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohit Tripathi
Also directs: En Ligne Entreprise (India) Private Limited, Brainrootz Labs Private Limited, Helios Cyber Security Research and Investigation Council
Director02 Dec 201015 Years 11 MonthsCurrent
Manish Tripathi
Also directs: En Ligne Entreprise (India) Private Limited, Brainrootz Labs Private Limited, Helios Cyber Security Research and Investigation Council
Director08 Feb 201610 Years 8 MonthsCurrent
View all directors

Auditor

Bryogen Pharmaceuticals Private Limited is audited by RCRJ & CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
RCRJ & CO.FY 2022024367N

Shareholding

The shareholding of Bryogen Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bryogen Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.03 Cr
Hdfc Bank Limited₹0.19 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Aug 2024100991048Hdfc Bank Limited₹7.07 LakhOpen
25 Apr 2024100934333Hdfc Bank Limited₹12.09 LakhOpen
31 Jul 2018100196924Others₹1.03 CrOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bryogen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bryogen Pharmaceuticals has 5 GST registrations: 4 active and 1 cancelled or inactive.

Total GSTINs
5
Active
4
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAECB3968P1Z1DelhiActive01 Jul 2017
36AAECB3968P1Z0TelanganaActive24 Dec 2022
33AAECB3968P1Z6Tamil NaduActive20 Jan 2023
24AAECB3968P1Z5GujaratActive11 Feb 2023

To see the full GST registrations and return filing status of Bryogen Pharmaceuticals Private Limited, buy the company report.

Recent activity

Bryogen Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Sudhakar Arya ceased to be Director on 11 Mar 2016.

AGM
Bryogen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bryogen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.07 Lakh with Charge ID 100991048 was registered on 27 Aug 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.09 Lakh with Charge ID 100934333 was registered on 25 Apr 2024.
Charges
A charge with Others amounted to Rs. 102.90 Lakh with Charge ID 100196924 was registered on 31 Jul 2018.
Ceased
Sudhakar Arya ceased to be Director.
Appointed
Manish Tripathi was appointed as Director.
Ceased
Rajesh Ahuja ceased to be Director.
Appointed
Rohit Tripathi was appointed as Director.
Incorporation
02 Dec 2010
Bryogen Pharmaceuticals Private Limited was registered on 02 Dec 2010 with Roc Haryana & aged 15 years 11 months as per MCA records.

Frequently asked questions

Bryogen Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 December 2010 (16+ years old) and is registered under CIN U24232HR2010PTC041648.

Bryogen Pharmaceuticals has 2 current directors:

The latest financial statements of Bryogen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bryogen Pharmaceuticals is 07AAECB3968P1Z1, registered in Delhi. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAECB3968P1Z0 (Telangana), 33AAECB3968P1Z6 (Tamil Nadu), 24AAECB3968P1Z5 (Gujarat).

The CIN (Corporate Identification Number) of Bryogen Pharmaceuticals is U24232HR2010PTC041648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bryogen Pharmaceuticals has 9 court cases on record: 6 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.

Bryogen Pharmaceuticals was incorporated on 02 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Haryana.

Sudhakar Arya ceased to be Director on 11 Mar 2016. Manish Tripathi was appointed as Director on 08 Feb 2016. Rajesh Ahuja ceased to be Director on 10 Jul 2011. Bryogen Pharmaceuticals has 4 board changes on record in total.

Yes, Bryogen Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-05-0006396).

Bryogen Pharmaceuticals can be reached through the website bryogen.in. Its registered office is in Gurgaon, Haryana, India.